查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2052185

轉化生長因子（TGF）市場：市場洞察、競爭格局與市場預測（2033 年）

Transforming Growth Factor Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 180 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

轉化生長因子 (TGF) 市場正經歷強勁成長，這主要得益於感染疾病、自體免疫疾病、癌症檢測和慢性病等領域對精準可靠的治療和診斷解決方案的需求不斷成長。人們對疾病早期檢測意識的提高以及先進免疫檢測和分子生物學技術的快速應用，進一步加速了市場擴張。預計到 2026 年，該市場規模將達到 4.0844 億美元，到 2033 年將達到 6.431 億美元，預測期內年複合成長率 (CAGR) 為 6.70%。

市場洞察：

在血清學、免疫診斷和細胞訊號傳導研究平台持續進步的推動下，該產業正經歷重大變革。酵素免疫分析法(ELISA) 和快速抗體檢測技術的廣泛應用，提高了診斷準確性，並顯著縮短了檢測結果的獲取時間。醫療機構和研究機構越來越依賴基於抗體和生長因子的檢測方法進行疾病監測、臨床研究和治療方法開發。此外，對實驗室基礎設施和生命科學研究投入的增加，也正在增強全球的檢測和分析能力。

成長要素：

關鍵成長要素包括慢性病和感染疾病率的上升、老年人口的成長以及對先進的照護現場診斷和研究解決方案日益成長的需求。政府旨在加強醫療基礎設施和改善疾病監測系統的措施也進一步推動了市場擴張。此外，自動化、高通量篩檢和生物資訊整合技術的進步也有助於提高檢查室效率、降低營運成本並改善研究成果。

商業機會：

該市場為專注於創新檢測試劑盒、重組蛋白和先進實驗室平台的生物技術公司、診斷設備製造商和研究解決方案供應商提供了巨大的成長機會。新興市場可望憑藉不斷完善的醫療保健體系、日益成長的研究經費以及預防醫學意識的提高而展現強勁的成長潛力。製藥公司、生技公司和學術研究機構之間的策略合作有望推動創新、加速產品開發並促進新技術商業化。

區域分析：

北美市場佔據主導地位，這得益於其強大的醫療基礎設施、先進的研究能力以及眾多大型生物技術和製藥公司的存在。歐洲緊隨其後，活躍的學術研究和有利的法規環境是其發展的驅動力。亞太地區預計將成為成長最快的地區，這主要得益於不斷成長的醫療投資、不斷擴大的研究生態系統以及龐大的患者群體。拉丁美洲、中東和非洲的醫療和研究基礎設施也在逐步改善，這些地區也為整體市場擴張做出了貢獻。

主要公司：

  • Genentech
  • Novartis
  • Pfizer
  • Roche
  • Merck & Co.
  • Johnson & Johnson
  • Amgen
  • Eli Lilly and Company
  • Sanofi
  • AstraZeneca
  • AbbVie
  • Bristol Myers Squibb

分割：

依產品類型

  • 骨形成蛋白（BMPs）
  • TGF-BETA蛋白

透過使用

  • 腫瘤學研究
  • 血液學研究
  • 創傷治療研究
  • 皮膚病學研究
  • 心血管疾病與糖尿病
  • 細胞療法和體外製造
  • 其他

按地區

  • 北美洲
  • 拉丁美洲
  • 北美洲
  • 東亞
  • 南亞和大洋洲

目錄

第1章執行摘要

第2章 市場概覽

  • 市場定義與細分
  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響
  • PESTLE分析
  • 監管分析
  • 價格趨勢分析
    • 當前價格及未來預測（2025-2033）
    • 價格影響因素

第3章：2020-2033年全球轉型成長因子市場展望

  • 全球轉型成長因子市場展望（依產品分類，價值單位：百萬美元），2020-2033年
    • 骨形成蛋白（BMPs）
    • TGF-BETA蛋白
  • 全球轉型成長因子市場展望（按應用領域分類，價值單位：百萬美元），2020-2033年
    • 腫瘤學研究
    • 血液學研究
    • 創傷治療研究
    • 皮膚病學研究
    • 心血管疾病與糖尿病
    • 細胞療法和體外製造
    • 其他
  • 全球轉型成長因子市場展望（按地區分類，價值單位：百萬美元），2020-2033年
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第4章：2020-2033年北美轉型成長因子市場展望

第5章：2020-2033年歐洲轉型成長因子市場展望

第6章：2020-2033年亞太地區轉型成長因子市場展望

第7章：2020-2033年拉丁美洲轉型成長因子市場展望

第8章：2020-2033年中東與非洲轉型成長因子市場展望

第9章 競爭情勢

  • 公司與細分市場熱圖
  • 2025年各公司市佔率分析
  • 競爭對手儀錶板
  • 公司簡介
    • Genentech
    • Novartis
    • Pfizer
    • Roche
    • Merck & Co.
    • Johnson & Johnson
    • Amgen
    • Eli Lilly and Company
    • Sanofi
    • AstraZeneca
    • AbbVie
    • Bristol Myers Squibb

第10章附錄

簡介目錄

The Transforming Growth Factor Market is witnessing robust growth, driven by increasing demand for precise and reliable therapeutic and diagnostic solutions across infectious diseases, autoimmune disorders, cancer research, and chronic conditions. Growing awareness of early disease detection and the rapid adoption of advanced immunoassay and molecular biology technologies are further accelerating market expansion. The market is projected to reach US$ 408.44 Mn in 2026 and US$ 643.1 Mn by 2033, registering a CAGR of 6.70% during the forecast period.

Market Insights:

The industry is undergoing significant transformation due to continuous advancements in serology, immunodiagnostics, and cellular signaling research platforms. The increasing utilization of enzyme-linked immunosorbent assays and rapid antibody detection technologies has improved diagnostic precision while significantly reducing turnaround time. Healthcare providers and research institutions are increasingly relying on antibody-based and growth factor-based assays for disease monitoring, clinical research, and therapeutic development. Moreover, rising investments in laboratory infrastructure and life sciences research are enhancing global testing and analytical capabilities.

Drivers:

Major growth drivers include the rising incidence of chronic and infectious diseases, increasing geriatric population, and expanding demand for advanced point-of-care diagnostic and research solutions. Government initiatives aimed at strengthening healthcare infrastructure and improving disease surveillance systems are further supporting market expansion. In addition, advancements in automation, high-throughput screening, and bioinformatics integration are helping laboratories improve efficiency, reduce operational costs, and enhance research output.

Business Opportunity:

The market presents substantial opportunities for biotechnology companies, diagnostic manufacturers, and research solution providers focused on innovative assay kits, recombinant proteins, and advanced laboratory platforms. Emerging economies offer strong growth potential due to improving healthcare systems, expanding research funding, and rising awareness of preventive healthcare. Strategic partnerships between pharmaceutical companies, biotechnology firms, and academic research institutes are expected to drive innovation, accelerate product development, and support commercialization of new technologies.

Region Analysis:

North America dominates the market, supported by strong healthcare infrastructure, advanced research capabilities, and the presence of leading biotechnology and pharmaceutical companies. Europe follows closely, driven by strong academic research activity and supportive regulatory environments. The Asia Pacific region is expected to witness the fastest growth due to increasing healthcare investments, expanding research ecosystems, and a large patient population base. Latin America and the Middle East and Africa are also experiencing gradual improvements in healthcare and research infrastructure, contributing to overall market expansion.

Key Players:

  • Genentech
  • Novartis
  • Pfizer
  • Roche
  • Merck & Co.
  • Johnson & Johnson
  • Amgen
  • Eli Lilly and Company
  • Sanofi
  • AstraZeneca
  • AbbVie
  • Bristol Myers Squibb

Segmentation:

By Product type

  • Bone Morphogenetic Proteins (BMPs)
  • TGF-beta Protein

By Application

  • Oncology Research
  • Hematology Research
  • Wound Healing Research
  • Dermatology Research
  • Cardiovascular Disease & Diabetes
  • Cell therapy and Ex vivo manufacturing
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania

Table of Contents

1. Executive Summary

  • 1.1. Global Transforming Growth Factor Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Transforming Growth Factor Market Outlook, 2020 - 2033

  • 3.1. Global Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 3.1.1. Bone Morphogenetic Proteins (BMPs)
    • 3.1.2. TGF-beta Protein
  • 3.2. Global Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 3.2.1. Oncology Research
    • 3.2.2. Hematology Research
    • 3.2.3. Wound Healing Research
    • 3.2.4. Dermatology Research
    • 3.2.5. Cardiovascular Disease & Diabetes
    • 3.2.6. Cell therapy and Ex vivo manufacturing
    • 3.2.7. Others
  • 3.3. Global Transforming Growth Factor Market Outlook, by Region, Value (US$ Mn), 2020-2033
    • 3.3.1. North America
    • 3.3.2. Europe
    • 3.3.3. Asia Pacific
    • 3.3.4. Latin America
    • 3.3.5. Middle East & Africa

4. North America Transforming Growth Factor Market Outlook, 2020 - 2033

  • 4.1. North America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 4.1.1. Bone Morphogenetic Proteins (BMPs)
    • 4.1.2. TGF-beta Protein
  • 4.2. North America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 4.2.1. Oncology Research
    • 4.2.2. Hematology Research
    • 4.2.3. Wound Healing Research
    • 4.2.4. Dermatology Research
    • 4.2.5. Cardiovascular Disease & Diabetes
    • 4.2.6. Cell therapy and Ex vivo manufacturing
    • 4.2.7. Others
  • 4.3. North America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 4.3.1. U.S. Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 4.3.2. U.S. Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 4.3.3. Canada Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 4.3.4. Canada Transforming Growth Factor Market Outlook, by Application, 2020-2033
  • 4.4. BPS Analysis/Market Attractiveness Analysis

5. Europe Transforming Growth Factor Market Outlook, 2020 - 2033

  • 5.1. Europe Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 5.1.1. Bone Morphogenetic Proteins (BMPs)
    • 5.1.2. TGF-beta Protein
  • 5.2. Europe Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 5.2.1. Oncology Research
    • 5.2.2. Hematology Research
    • 5.2.3. Wound Healing Research
    • 5.2.4. Dermatology Research
    • 5.2.5. Cardiovascular Disease & Diabetes
    • 5.2.6. Cell therapy and Ex vivo manufacturing
    • 5.2.7. Others
  • 5.3. Europe Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 5.3.1. Germany Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 5.3.2. Germany Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 5.3.3. Italy Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 5.3.4. Italy Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 5.3.5. France Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 5.3.6. France Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 5.3.7. U.K. Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 5.3.8. U.K. Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 5.3.9. Spain Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 5.3.10. Spain Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 5.3.11. Russia Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 5.3.12. Russia Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 5.3.13. Rest of Europe Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 5.3.14. Rest of Europe Transforming Growth Factor Market Outlook, by Application, 2020-2033
  • 5.4. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Transforming Growth Factor Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 6.1.1. Bone Morphogenetic Proteins (BMPs)
    • 6.1.2. TGF-beta Protein
  • 6.2. Asia Pacific Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 6.2.1. Oncology Research
    • 6.2.2. Hematology Research
    • 6.2.3. Wound Healing Research
    • 6.2.4. Dermatology Research
    • 6.2.5. Cardiovascular Disease & Diabetes
    • 6.2.6. Cell therapy and Ex vivo manufacturing
    • 6.2.7. Others
  • 6.3. Asia Pacific Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 6.3.1. China Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 6.3.2. China Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 6.3.3. Japan Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 6.3.4. Japan Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 6.3.5. South Korea Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 6.3.6. South Korea Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 6.3.7. India Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 6.3.8. India Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 6.3.9. Southeast Asia Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 6.3.10. Southeast Asia Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 6.3.11. Rest of SAO Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 6.3.12. Rest of SAO Transforming Growth Factor Market Outlook, by Application, 2020-2033
  • 6.4. BPS Analysis/Market Attractiveness Analysis

7. Latin America Transforming Growth Factor Market Outlook, 2020 - 2033

  • 7.1. Latin America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 7.1.1. Bone Morphogenetic Proteins (BMPs)
    • 7.1.2. TGF-beta Protein
  • 7.2. Latin America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 7.2.1. Oncology Research
    • 7.2.2. Hematology Research
    • 7.2.3. Wound Healing Research
    • 7.2.4. Dermatology Research
    • 7.2.5. Cardiovascular Disease & Diabetes
    • 7.2.6. Cell therapy and Ex vivo manufacturing
    • 7.2.7. Others
  • 7.3. Latin America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 7.3.1. Brazil Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 7.3.2. Brazil Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 7.3.3. Mexico Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 7.3.4. Mexico Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 7.3.5. Argentina Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 7.3.6. Argentina Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 7.3.7. Rest of LATAM Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 7.3.8. Rest of LATAM Transforming Growth Factor Market Outlook, by Application, 2020-2033
  • 7.4. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Transforming Growth Factor Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 8.1.1. Bone Morphogenetic Proteins (BMPs)
    • 8.1.2. TGF-beta Protein
  • 8.2. Middle East & Africa Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 8.2.1. Oncology Research
    • 8.2.2. Hematology Research
    • 8.2.3. Wound Healing Research
    • 8.2.4. Dermatology Research
    • 8.2.5. Cardiovascular Disease & Diabetes
    • 8.2.6. Cell therapy and Ex vivo manufacturing
    • 8.2.7. Others
  • 8.3. Middle East & Africa Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 8.3.1. GCC Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 8.3.2. GCC Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 8.3.3. South Africa Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 8.3.4. South Africa Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 8.3.5. Egypt Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 8.3.6. Egypt Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 8.3.7. Nigeria Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 8.3.8. Nigeria Transforming Growth Factor Market Outlook, by Application, 2020-2033
    • 8.3.9. Rest of Middle East Transforming Growth Factor Market Outlook, by Product, 2020-2033
    • 8.3.10. Rest of Middle East Transforming Growth Factor Market Outlook, by Application, 2020-2033
  • 8.4. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Genentech
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Novartis
    • 9.4.3. Pfizer
    • 9.4.4. Roche
    • 9.4.5. Merck & Co.
    • 9.4.6. Johnson & Johnson
    • 9.4.7. Amgen
    • 9.4.8. Eli Lilly and Company
    • 9.4.9. Sanofi
    • 9.4.10. AstraZeneca
    • 9.4.11. AbbVie
    • 9.4.12. Bristol Myers Squibb

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations